Literature DB >> 27306762

Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia.

Michael Strupp1,2, Marianne Dieterich3,4,5, Thomas Brandt3,6, Katharina Feil3,4.   

Abstract

OPINION STATEMENT: Neurovascular compression syndromes are characterized by recurrent attacks of neurological symptoms and clinical signs depending on the cranial nerve affected. It is assumed that pulsatile compression of the nerve is caused mainly by an artery. The result is segmental demyelination of the transition zone or the central part of the cranial nerve, which is covered by oligodendrocytes, and subsequent ephaptic axonal transmission. Compression of the vestibular nerve can cause attacks of spinning or non-spinning vertigo: vestibular paroxysmia. Compression of the trochlear nerve is characterized by attacks of monocular oscillopsia: superior oblique myokymia. Damage to ocular motor nerves due to local radiation or rarely neurovascular compression can also lead to oscillopsia and double vision precipitated by sustained excentric gaze: ocular neuromyotonia. It is important to note that controlled trials have so far not been performed for any of these three syndromes, mainly because of their low prevalence. Therefore, treatment recommendations are based on single cases or small case series and thus have the lowest level of evidence. The sodium channel blockers carbamazepine (50 to 200 mg tid) or oxcarbazepine (100 to 300 mg tid) are evidently effective in most of the patients who have these three syndromes. However, one should always keep in mind the contraindications, side effects, and interactions with other drugs of carbamazepine ( http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682237.html ) All patients require regular laboratory examinations. Alternatives are other sodium channel blockers such as phenytoin (100 to 300 mg tid), gabapentin (100 to 600 mg tid), or valproic acid (100 to 300 mg tid). Furthermore, there are also few reports on the effects of beta blockers, which may be explained by their reduction of the amplitude of blood pressure. Patients who do not respond to pharmacotherapy require further diagnostics to determine the possibility of other etiologies. Some of these patients benefit from surgical decompression of the affected nerve.

Entities:  

Keywords:  Carbamazepine; Neurovascular compression; Oxcarbazepine; Sodium channel

Year:  2016        PMID: 27306762     DOI: 10.1007/s11940-016-0417-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  71 in total

1.  Recurrent attacks of vertigo with monocular oscillopsia.

Authors:  Katharina Hüfner; Jennifer Linn; Michael Strupp
Journal:  Neurology       Date:  2008-09-09       Impact factor: 9.910

2.  Ocular neuromyotonia 18 years after radiation therapy.

Authors:  C L Haupert; N J Newman
Journal:  Arch Ophthalmol       Date:  1997-10

3.  Vestibular paroxysmia in children: a treatable cause of short vertigo attacks.

Authors:  Nadine Lehnen; Thyra Langhagen; Florian Heinen; Doreen Huppert; Thomas Brandt; Klaus Jahn
Journal:  Dev Med Child Neurol       Date:  2014-08-22       Impact factor: 5.449

4.  Ocular neuromyotonia treated by microvascular decompression: usefulness of preoperative 3D imaging: case report.

Authors:  Takuro Inoue; Hisao Hirai; Toshiki Shimizu; Masayuki Tsuji; Ayako Shima; Fumio Suzuki; Masayuki Matsuda
Journal:  J Neurosurg       Date:  2012-09-28       Impact factor: 5.115

5.  Remission of superior oblique myokymia after microvascular decompression.

Authors:  K Scharwey; T Krzizok; M Samii; S K Rosahl; H Kaufmann
Journal:  Ophthalmologica       Date:  2000       Impact factor: 3.250

6.  Ocular Neuromyotonia and Myasthenia Gravis.

Authors:  JunWon Jang; Moohwan Chang; Sungeun Kyung
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2015 May-Jun       Impact factor: 1.402

Review 7.  Ocular neuromyotonia in Graves dysthyroid orbitopathy.

Authors:  S M Chung; A G Lee; J B Holds; G Roper-Hall; O A Cruz
Journal:  Arch Ophthalmol       Date:  1997-03

8.  Superior oblique myokymia. Quantitative characteristics of the eye movements in three patients.

Authors:  R J Leigh; R L Tomsak; S H Seidman; L F Dell'Osso
Journal:  Arch Ophthalmol       Date:  1991-12

9.  [Clinical manifestations and imaging features of peripheral vestibular paroxysmia: a report of 7 cases].

Authors:  Lan-ying He; Wei-wei Dong; Wen Huang; Yong Luo; Fa-jin Lü
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2009-04-07

10.  Ocular neuromyotonia. A clinical description of six patients.

Authors:  W T Shults; W F Hoyt; M Behrens; J MacLean; R F Saul; J J Corbett
Journal:  Arch Ophthalmol       Date:  1986-07
View more
  5 in total

1.  Treatment of vestibular paroxysmia with lacosamide.

Authors:  Michael Strupp; Christian Elger; Nicolina Goldschagg
Journal:  Neurol Clin Pract       Date:  2019-12

2.  A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine.

Authors:  Otmar Bayer; Tatiana Brémová; Michael Strupp; Katharina Hüfner
Journal:  J Neurol       Date:  2017-11-27       Impact factor: 4.849

3.  Ocular neuromyotonia caused by a recurrent sphenoidal ridge meningioma.

Authors:  Yuto Shingai; Hidenori Endo; Toshiki Endo; Shin-Ichiro Osawa; Kuniyasu Nizuma; Teiji Tominaga
Journal:  Surg Neurol Int       Date:  2021-05-10

4.  Vestibular paroxysmia: Diagnostic criteria.

Authors:  Michael Strupp; Jose A Lopez-Escamez; Ji-Soo Kim; Dominik Straumann; Joanna C Jen; John Carey; Alexandre Bisdorff; Thomas Brandt
Journal:  J Vestib Res       Date:  2016       Impact factor: 2.354

Review 5.  Neurotology: definitions and evidence-based therapies - Results of the I Brazilian Forum of Neurotology.

Authors:  Márcio Cavalcante Salmito; Francisco Carlos Zuma E Maia; Mário Edvin Gretes; Alessandra Venosa; Fernando Freitas Ganança; Maurício Malavasi Ganança; Raquel Mezzalira; Roseli Saraiva Moreira Bittar; Alexandre Camilotti Gasperin; Anna Paula Batista de Ávila Pires; Bernardo Faria Ramos; César Bertoldo; Cícero Ferreira; Danilo Real; Humberto Afonso Guimarães; Jeanne Oiticica; Joel Lavinsky; Karen Carvalho Lopes; Juliana Antoniolli Duarte; Lígia Oliveira Gonçalves Morganti; Lisandra Megumi Arima Dos Santos; Lúcia Joffily; Luíz Lavinsky; Mônica Alcantara de Oliveira Santos; Patrícia Mauro Mano; Pedro Ivo Machado Pires de Araújo; Pedro Luís Mangabeira Albernaz; Renato Cal; Ricardo Schaffeln Dorigueto; Rita de Cássia Cassou Guimarães; Rogério Castro Borges de Carvalho
Journal:  Braz J Otorhinolaryngol       Date:  2019-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.